Literature DB >> 10066431

The identification and characterization of two promoters and the complete genomic sequence for the Wiskott-Aldrich syndrome gene.

T L Hagemann1, S P Kwan.   

Abstract

The Wiskott-Aldrich syndrome (WAS) is an X-linked disorder characterized by immunodeficiency, eczema and thrombocytopenia. The gene responsible for WAS was identified through positional cloning, and the function of the encoded protein (WASP) is still the subject of much speculation. WASP is currently thought to be involved in the regulation of actin polymerization in hematopoietic cells. To study the elements that regulate the WASP gene, we have identified the sites for transcription initiation. We found that two promoters were responsible for controlling WASP expression. Multiple transcription initiation sites were found immediately adjacent to the translation start site, however an alternate exon with a second promoter region was identified 6 kb upstream. Examination of the 5' sequence adjacent to the initiation sites in both promoters failed to reveal a TATA or CCAAT box, but numerous putative transcription factor binding sites including Sp1, Ets, c-Myb and PU.1 were apparent. Reporter constructs generated from each promoter showed functional activity in the Jurkat T-cell and HEL erythro-megakaryocytic cell lines. Although the alternate exon sequence was extremely GC rich and contained several potential binding elements, the primary promoter was stronger than the upstream promoter in the cell lines assayed. The transcription factor binding site profiles within each promoter suggested that they may play different roles in regulating WASP expression depending on the stage of differentiation and development, and the cell lineage. In this study we have also reported the complete nucleotide sequence of the coding and intervening sequences for the WASP gene. A comprehensive knowledge of the genomic structure and the further characterization of WASP gene expression will facilitate the continued investigation of mutations in WAS patients, and the eventual prospect of gene therapy. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10066431     DOI: 10.1006/bbrc.1999.0292

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome.

Authors:  Alexander Astrakhan; Blythe D Sather; Byoung Y Ryu; Socheath Khim; Swati Singh; Stephanie Humblet-Baron; Hans D Ochs; Carol H Miao; David J Rawlings
Journal:  Blood       Date:  2012-03-19       Impact factor: 22.113

2.  X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3.

Authors:  C L Bennett; R Yoshioka; H Kiyosawa; D F Barker; P R Fain; A O Shigeoka; P F Chance
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

Review 3.  Wiskott-Aldrich syndrome.

Authors:  S Nonoyama; H D Ochs
Journal:  Curr Allergy Asthma Rep       Date:  2001-09       Impact factor: 4.806

Review 4.  Development of lentiviral gene therapy for Wiskott Aldrich syndrome.

Authors:  Anne Galy; Maria-Grazia Roncarolo; Adrian J Thrasher
Journal:  Expert Opin Biol Ther       Date:  2008-02       Impact factor: 4.388

5.  Specific marking of hESCs-derived hematopoietic lineage by WAS-promoter driven lentiviral vectors.

Authors:  Pilar Muñoz; Miguel G Toscano; Pedro J Real; Karim Benabdellah; Marién Cobo; Clara Bueno; Verónica Ramos-Mejía; Pablo Menendez; Per Anderson; Francisco Martín
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

6.  Generation of a lentiviral vector producer cell clone for human Wiskott-Aldrich syndrome gene therapy.

Authors:  Matthew M Wielgosz; Yoon-Sang Kim; Gael G Carney; Jun Zhan; Muralidhar Reddivari; Terry Coop; Richard J Heath; Scott A Brown; Arthur W Nienhuis
Journal:  Mol Ther Methods Clin Dev       Date:  2015-01-21       Impact factor: 6.698

Review 7.  The identification of hematopoietic-specific regulatory elements for WASp gene expression.

Authors:  Jun Zhan; Irudayam Maria Johnson; Matthew Wielgosz; Arthur W Nienhuis
Journal:  Mol Ther Methods Clin Dev       Date:  2016-12-14       Impact factor: 6.698

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.